IL33 and rheumatoid arthritis: This research aimed to investigate the potential of IL-33 gene polymorphisms as predictors of disease susceptibility and biomarkers of anti-TNF therapy response in major autoimmune rheumatic diseases, including RA, AS, and PsA.